| Voigt, Thor (Boehringer 1992–201903 CMO RETIRED 4/19) |
Chief Medical Officer (CMO) |
Boehringer Ingelheim (Group) |
Germany |
| Voigt, Tobias (Sachsen (govt) 201905 at Technologiegründerfonds Sachsen) |
n. a. |
Saxony (govt region) |
Germany |
| Volckmar, Klaus (LabWare 201003 Head German Office) |
President/Director/Head Business Group/Unit/Division |
LabWare (Group) |
Germany |
| Voliotis, Dimitris (CureVac 201901– CDO before Eisai Inc + 12years at Bayer HealthCare) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
CureVac (Group) |
United States (USA) |
| Vollertsen, Frank (BIAS 201104 Managing Director) |
Managing Director |
BIAS Bremer Institut für angewandte Strahltechnik GmbH |
Germany |
| Vollmer, Jörg (Abalos Therapeutics 201910– CSO before Rigontec + Nexigen) |
Managing Director |
Abalos Therapeutics GmbH |
Germany |
| Volmer, Dietrich (Saarland Univ 201005– Professor for Analytical Chemistry before Univ Cambridge before Dalhousie Univ) |
Professor |
Saarland University (Universität des Saarlandes) |
Germany |
| von Alvensleben, Konstantin (Riemser Pharma 202001 Managing Director (CEO) before Takeda Pharma GmbH) |
Managing Director |
Esteve (Group) |
Germany |
| von Baumbach, Hubertus (Boehringer Ingelheim 201609 Chairman before Managing Director Finance) |
Managing Director |
Boehringer Ingelheim (Group) |
Germany |
| von Berg, Martin (Gilde Investment, 202207– Investment Manager at Gilde Healthcare in Ffm before 3i + Halder + BofA) |
Investment Manager |
Gilde Investment (Group) |
Germany |
| von Bohlen, Friedrich (Dievini before Lion Bioscience) |
Investment Manager |
HOPP Group (family of Dietmar Hopp) |
Germany |
| von Bonin, Arne (Actelion 201608– CSO of Vaxxilon before Affiris + Bayer HealthCare + Schering) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Idorsia (Group) |
Switzerland |
| von Braun, Joachim (Chairman of German Bioeconomy Council) |
Advisory Board member |
Biocom (Group) |
Germany |
| von Braunmühl, Benedikt (HMNC 202105– CEO before Medicover AB + Qiagen + Novartis Vaccines & Diagnostics) |
Chief Executive Officer (CEO) |
HMNC (Holsboer / Maschmeyer) (Group) |
Germany |
| von Capeller, Gaudenz (Cellestia Biotech 201707– CFO Piqur Therapeutics 201507 CEO) |
Chief Financial Officer (CFO) |
Cellestia Biotech AG |
Switzerland |
| von Dahlen, Guido (LabWare 201003 Sales Manager Life Science) |
Sales Manager / Marketing Manager |
LabWare (Group) |
Germany |
| von Dalwigk, Friedrich (Analyticon Biotechnologies 2007 CEO) |
Chief Executive Officer (CEO) |
Analyticon Biotechnologies AG |
Germany |
| von Dalwigk, Reinhard (Analyticon Biotechnologies 201105 Executive Board Chairman) |
Board member, executive |
Analyticon Biotechnologies AG |
Germany |
| von Degenfeld, Georges (iAtros GmbH 202003 Managing Director + Co-Founder) |
Managing Director |
iAtros GmbH |
Germany |
| von der Mülbe, Florian (CureVac 201706 COO + Co-Founder) |
Chief Operating Officer (COO) |
CureVac (Group) |
Germany |
| von der Osten, Dinnies Johannes (GoodVent 201109 Managing Director (geschäftsf Kommanditist)) |
Managing Director |
GoodVent Beteiligungsmanagement GmbH & Co KG |
Germany |
| von der Weid, Sandya (LifeSci Advisors 202101 before Debiopharm) |
n. a. |
LifeSci (Group) |
United States (USA) |
| von Eggeling, Ferdinand (Univ Jena 201112 Professor) |
Professor |
University of Jena (Friedrich-Schiller-Universität Jena) |
Germany |
| von Einem, Christoph (White & Chase 200809 Munich) |
n. a. |
White & Case (Group) |
Germany |
| von Emster, Kurt (Abingworth 201507– Managing Partner joined 201501 before venBio + MPM Capital + Franklin Templeton) |
Managing Partner (investment firm) |
Abingworth (Group) |
United States (USA) |
| von Frankenberg, Alex (High-Tech Gründer Gründerfonds 201209 Managing Director) |
Managing Director |
High-Tech Gründerfonds (HTGF) (Group) |
Germany |
| von Gabain, Alexander (Intercell 200311) |
n. a. |
Valneva (Group) |
Austria |
| von Glass, Birgitta (BioM 201804 Marketing + Communications) |
Public Relations Manager / Investor Relations Manager |
Bavaria (govt region) |
Germany |
| von Gordon, Judith (Boehringer Ingelheim 201405 Head of Global Media + PR) |
Public Relations Manager / Investor Relations Manager |
Boehringer Ingelheim (Group) |
Germany |
| von Grotthuss, Moritz (Immungenetics GmbH 201101 Managing Director) |
Managing Director |
Innoveas (Group) |
Germany |
| von Halem, Carl (Xlife Sciences 202112– CFO before CommneX + SaEnergy Systems) |
Chief Financial Officer (CFO) |
Xlife Sciences AG (SIX: XLS) |
Switzerland |
| von Heijne, Johan (Ratos 201501 CEO of Biolin Scientific) |
Chief Executive Officer (CEO) |
Ratos (Group) |
Sweden |
| von Herrmann, Bruce (Agilent 200708 General Manager + VP Software Div) |
General Manager (management) |
Agilent (Group) |
United States (USA) |
| von Hohenthal, Balthasar (Spitality GmbH 201809– Managing Director + Co-Founder before KSB Klinkberatung) |
Managing Director |
Spitality GmbH |
Germany |
| von Horsten, Hans Henning (HTW Berlin 201505 Professor at Dept Engineering II, SG Life Sciene Engineering) |
Professor |
HTW Berlin – Hochschule für Technik und Wirtschaft Berlin (University of Applied Sciences Berlin) |
Germany |
| von Hummel, Julia (MC Services 201811) |
Public Relations Manager / Investor Relations Manager |
MC Services AG |
Germany |
| von Keyserling, Helmut (SpreeLabs 201106 Managing Director + Co-founder) |
Managing Director |
SpreeLabs UG (haftungsbeschränkt) |
Germany |
| von Klitzing, Bettina (4SC 200901 Manager Public Realtions + Investor Relations) |
Public Relations Manager / Investor Relations Manager |
4SC (Group) |
Germany |
| von König, Cajetan (Miracor 201407– Director of Sales + Marketing) |
Sales Manager / Marketing Manager |
Miracor (Group) |
Austria |
| von Laer, Dorothee (ViraTherapeutics 201609 CEO + Scientific Founder) |
Chief Executive Officer (CEO) |
Boehringer Ingelheim (Group) |
Austria |
| von Leoprechting, Achim (Tecan 201904– CEO joined 201310 before PerkinElmer + Packard Bioscience) |
Business Development Manager / Strategy Manager |
Tecan (Group) |
Switzerland |
| von Loeper, Philipp (Eppendorf 201606– Chair of Supervisory Board joined Supervisory Board in 2011) |
Supervisory Board Member |
Eppendorf (Group) |
Germany |
| von Mangoldt, Karl (Protembis GmbH 2013– Managing Director + Co-Founder) |
Managing Director |
Protembis GmbH |
Germany |
| von Mehring, Christian |
n. a. |
EMBL (European Molecular Biology Laboratory) |
Germany |
| von Meiborn, Wolfgang (Bird & Bird 200809) |
n. a. |
Bird & Bird (Group) |
Germany |
| von Meier, Sandra (Merck (DE) 201404– Director Bus Dev Oncology before Medigene) |
Business Development Manager / Strategy Manager |
Merck (DE) (Group) |
Germany |
| von Rickenbach, Josef (Parexel 201706 CEO) |
Chief Executive Officer (CEO) |
Parexel (Group) |
United States (USA) |
| von Rundstedt, Friederike (Bock Bio Science 200906 Managing Director) |
Managing Director |
Bock Bio Science (Group) |
Germany |
| von Rüden, Thomas (Direvo Biotech –201004 CEO STEPPED DOWN 4/19 before MorphoSys) |
Chief Executive Officer (CEO) |
Bayer (Group) |
Germany |
| von Schacky, Clemens (Omegametrix GmbH 201807 Managing Director) |
Managing Director |
Omegametrix GmbH |
Germany |
| von Schroeders, Nikolai (Spitality GmbH 201809– Co-Founder before KSB Klinkberatung) |
Managing Director |
Spitality GmbH |
Germany |
| von Schulthess, Konstantin (CDR-Life 202204 CFO) |
Chief Financial Officer (CFO) |
CDR-Life AG |
Switzerland |
| von Schönfels, Philipp (Alcedo Biotech 200612 Managing Director) |
Managing Director |
Alcedo Biotech GmbH |
Germany |
| von Velasco, Sabine (ERC GmbH 201106 Marketing) |
Sales Manager / Marketing Manager |
ERC Gesellschaft für den Vertrieb wissenschaftlicher Geräte mbH (ERC GmbH) |
Germany |
| von Volkmann, Christian (MagForce 201205– Head of Finance before Jerini CFO + Ernst & Young) |
Chief Financial Officer (CFO) |
MagForce (Group) |
Germany |
| von Walcke-Wulffen, Vincent-Joachim (BioKryo GmbH 201110 Managing Director) |
Managing Director |
Air Liquide (Group) |
Germany |
| Vonder Mühll, Daniel (SystemsX.ch 201104 Managing Director) |
Managing Director |
SystemsX.ch project (CH, 2004) |
Switzerland |
| Vonlanthen, Nadine (Basilea 201211 Licensing Manager, BusDev + Licensing) |
Business Development Manager / Strategy Manager |
Basilea (Group) |
Switzerland |
| Vonnahme, Marcel (eCapital 2012 201211 Investment Manager) |
Investment Manager |
eCapital (Group) |
Germany |
| Vonnemann, Jonathan (Scitaris 202204 Managing Partner) |
Managing Partner |
Scitaris (Group) |
Germany |
| Vorbrodt, Hans-Matthias (Orgentis Chemicals GmbH 201102 Managing Director) |
Managing Director |
Orgentis Chemicals GmbH |
Germany |
| Vorm, Ole (Evosep 202301 Founder before Bruker + Thermo Fisher + Proxeon) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Evosep ApS |
Denmark |
| Vormschlag, Knud (Polyplan GmbH 200902 Managing Director) |
Managing Director |
Polyplan (Group) |
Germany |
| Vornlocher, Hans-Peter (Roche Kulmbach 200809 CSO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
LGC (Group) |
Germany |
| Vos, Alexander (VectorY 202106– CEO before VarmX + Paion + Genzyme Europe + PharmaCell) |
Chief Executive Officer (CEO) |
VectorY (Group) |
Netherlands |
| Voss, Hartmut (MCG Motion Capture 201910 Managing Director) |
Managing Director |
MCG Motion Capture GmbH (Motion Capture Group) |
Germany |
| Voss, Jörn (Fassisi 201102 Managing Director) |
Managing Director |
Fassisi, Gesellschaft für Veterinärdiagnostik und Umweltanalysen mbH |
Germany |
| Voswinkel, Stephan (MLM Medical Labs 202010 Managing Director) |
Managing Director |
MLM Medical Labs (Group) |
Germany |
| Vuagniaux, Gregoire (Debiopharm 201905 Director of Translational Science) |
n. a. |
Debiopharm (Group) |
Switzerland |
| Vujevic, Manuela (InSphero 201311 Head of Marketing Communications) |
Sales Manager / Marketing Manager |
InSphero (Group) |
Switzerland |
| Vulto, Paul (Mimetas 201708 Managing Director) |
Managing Director |
Mimetas B.V. |
Netherlands |
| Vunder, Kadri (Aravis 201307– Partner in life science team before LSVenture) |
Managing Partner (investment firm) |
Aravis (Group) |
Switzerland |
| Vögtli, Martin (Sal Oppenheim 200809 Analyst) |
Analyst (Financial / Industry) |
Sal. Oppenheim (Group) |
Germany |
| Völker, Lutz (Molecular Health 201511 CEO) |
Chief Executive Officer (CEO) |
Molecular Health (Group) |
Germany |
| Völker, Sonja (Bayern (govt) 201301 Project Manager at IBB Netzwerk GmbH) |
n. a. |
Bavaria (govt region) |
Germany |
| Völker-Albert, Moritz (EpiQMAx GmbH 201903 Managing Director + Co-Founder) |
Managing Director |
EpiQMAx GmbH |
Germany |
| Vössing, Dagmar (Karlsruhe Institute of Technology 201307 Head Business Development) |
Business Development Manager / Strategy Manager |
Karlsruhe Institute of Technology (KIT) |
Germany |
| Wachenfeld, Joachim (Vossius & Partner 200310–200708–) |
n. a. |
Vossius & Partner patent attorneys |
Germany |
| Wachsmuth, Malte (Bruker 202301 Managing Director for Luxendo Light Sheet Microscopy Business) |
Managing Director |
Bruker (Group) |
Germany |
| Wacker, Michael (BioMedPartners 202007 before Polyneuron 201805– CBO before GlycoVaxyn CSO + Co-Founder) |
Chief Business Officer (CBO) |
BioMedPartners (Group) |
Switzerland |
| Wacker, Peter-Alexander (Wacker 200501 CEO) |
Chief Executive Officer (CEO) |
Wacker (Group) |
Germany |
| Wacker, Ron (SGS 201106– Global BusDev Manager Food Testing before Danone + Chimera Biotec) |
Business Development Manager / Strategy Manager |
SGS (Group) |
Switzerland |
| Waddington, Simon (Evolva 201707–201807 CEO before COO before Abunda Nutrition CEO RESIGNED 7/18) |
Chief Executive Officer (CEO) |
Evolva (Group) |
Switzerland |
| Wadsworth-Hansen, Victoria (Agilent 201506 Director Global Business Public Relations) |
Public Relations Manager / Investor Relations Manager |
Agilent (Group) |
United States (USA) |
| Wadzack, Jörg |
n. a. |
Humangenomprojekt (DE) |
Germany |
| Wagemann, Bernd (Scienion 200312 Scientific Advisory Board) |
Advisory Board member |
Bico (Group) |
Germany |
| Wagenbauer, Klaus (Plectonic Biotech 202211 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Plectonic Biotech GmbH |
Germany |
| Wagener, Michael (Bio-Gate AG 201104 CTO) |
Chief Technology/Technical Officer (CTO) |
Bio-Gate (Group) |
Germany |
| Wager, Jeffrey D. (EnBiotix 201611 CEO) |
Chief Executive Officer (CEO) |
Spexis (Group) |
United States (USA) |
| Wagner, Amanda (Immunitas Therapeutics 202108– promoted to CBO joined 201910 as VP of Strategy before Q32 Bio + Concert) |
Business Development Manager / Strategy Manager |
Immunitas Therapeutics Inc. |
United States (USA) |
| Wagner, Anke (BioNukleo GmbH 201808 Managing Partner) |
Managing Director |
BioNukleo GmbH |
Germany |
| Wagner, Carola (Siemens 200909 Senior Manager Sientific Marketing Siemens Healthcare) |
Sales Manager / Marketing Manager |
Siemens (Group) |
Germany |
| Wagner, Charles F., Jr. (JnJ 201506– CFO at Ortho-Clinical Diagnostics before CFO at Bruker + Millipore + Bain & Co) |
Chief Financial Officer (CFO) |
Quidel (Group) |
United States (USA) |
| Wagner, Christina (Temedica 202110– CFO before coliquio + OmniaMed Holding + Ventac Partners + Inveni Capital + MWG) |
Chief Financial Officer (CFO) |
Temedica GmbH |
Germany |
| Wagner, Florian (Biopharm GmbH 201311 Managing Director + PW Technologies 201402 Managin Director) |
Managing Director |
Biopharm (Group) |
Germany |
| Wagner, Gerhard (Harvard Univ 1990– Prof at Harvard Medical School before Univ Michigan + ETHZ) |
Professor |
Harvard University |
United States (USA) |
| Wagner, Günter (Kibion 201108 Exec Sales + Marketing Director ISIS before Wagner Analysen 1990–201107 Managing Director) |
Sales Manager / Marketing Manager |
Mayoly Spindler (Group) |
Sweden |
| Wagner, Harro (Biotest 201103 Managing Director of Heipha Dr Müller GmbH) |
Managing Director |
Merck (DE) (Group) |
Germany |
| Wagner, Julian (Pevion Biotech 201110 Business Development) |
Business Development Manager / Strategy Manager |
Pevion Biotech AG |
Switzerland |
| Wagner, Nicole (Applied Biosystems D 200512) |
n. a. |
Thermo Fisher (Group) |
Germany |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo.svg){kind=logo}
1 2 3 ... 77 78 79 ... 83 84 85 
![Picture [iito] [LSE] Life-Sciences-Europe.com Business Portal 650x200px](/banner/iito-business-intelligence-20220406-650-200-lse-life-sciences-europe.jpg)
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20111029-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px](/banner/iito-20150801-120-600-lse-life-sciences-europe-com.jpg)
